B

Alireza Mohebbi1,2,3,4, Seyed Pooria Tadayon Nabavi5, Malihe Naderi6,4,7

  • 1Student Research Committee, Iran University of Medical Sciences, Tehran, Iran.

In silico pharmacology
|February 28, 2025
PubMed
概括

计算机辅助药物重定位识别了FDA批准的药物,如他类药物,以破坏乙型肝炎病毒 (HBV) 核心蛋白质组装. 这为慢性乙型肝炎感染提供了新的治疗策略,有可能克服耐药性.